Researchers in the Perelman School of Medicine at the University of Pennsylvania found that, across a variety of neurodegenerative diseases, cerebrovascular disease affecting circulation of blood in the brain was significantly associated with dementia. The researchers contend that people already...
JAMA Neurology Study Highlights In a study of elderly patients, Natalie L. Marchant, Ph.D., of the University of California, Berkeley, and colleagues suggest there is no evidence that vascular brain injury (VBI) increases the likelihood of beta-Amyloid (Aβ) deposition, a diagnostic criterion...
Efforts to understand how the aging process affects the brain and cognition have expanded beyond simply comparing younger and older adults. "Everybody ages differently. By looking at genetic variations and individual differences in markers of vascular health, we begin to understand that...
A specific genetic alteration has been discovered as a defining feature of epithelioid hemangioendothelioma (EHE), a rare but devastating vascular cancer. These findings have also been used to develop a new diagnostic test for this blood vessel disease. An international research effort led by...
Atlanta Vascular Research Foundation (AVRF), together with its collaborators at the University of Prince Edward Island (UPEI), has been awarded an Innovation PEI Pilot and Discovery Fund grant by Innovation PEI. The grant is to continue research and development in combining nutraceuticals to...
W. L. Gore & Associates (Gore) joined with leaders from across the vascular and endovascular community to honor a distinguished group of eight physicians receiving the 2010 Pioneers in Performance Awards-an annual recognition for physicians demonstrating an unrelenting dedication to advancing...
Experimental drug Vytorin (ezetimibe/simvastatin) was found to lower the risk of major vascular events by 16.1% compared to a placebo for patients with chronic kidney disease, Merck & Co announced today. Vytorin is a cholesterol lowering medication. Examples of major vascular events are...
The Society for Vascular Surgery® (SVS) announced a new quality initiative to improve the care of patients with vascular disease. The Vascular Quality Improvement Initiative includes a registry and regional study groups to analyze the data collected from the registry. The initiative expands SVS'...
One of only a handful of physicians with formal training in both vascular surgery and interventional radiology, Dr. Darren B. Schneider has been appointed chief of vascular and endovascular surgery and director of the Center for Vascular and Endovascular Surgery at NewYork-Presbyterian...
Approximately 9 million Americans have peripheral arterial disease (P.A.D.), a common and dangerous vascular disease that can lead to heart attack, stroke, amputation and death. Unfortunately, many with the disease do not even know they have it. September is P.A.D. Awareness Month, and the...
Dr. Richard P. Cambria was elected 2010-2011 president-elect of the Society for Vascular Surgery® (SVS) during the Vascular Annual Meeting® on June 11, 2010. He is chief of the Division of Vascular and Endovascular Surgery and co-director of Thoracic Aortic Center at Massachusetts General...
Volcano Corporation (NASDAQ: VOLC) announced that it has received CE Mark approval for the VIBE™ RX Vascular Imaging Balloon Catheter. The company also announced that it has completed its first clinical cases with the VIBE™ RX in New Zealand. A single VIBE™ RX Catheter can quickly access...
Most solid cancers can't grow beyond a limited size without an adequate blood supply and supporting vascular network. Because of this, cancer researchers have sought to understand how a tumor's vascular network develops - and, more importantly, how to prevent it from developing: If the vascular...
BioMedix Vascular Solutions, Inc. announced that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral...
BioMedix Vascular Solutions, Inc. announced that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral...